Therapeutic effect of fermented milk on chronic gastritis

Apr 09, 2010

A research team from Argentina investigated the potential therapeutic effect of exopolysaccharide (EPS)-producing Streptococcus thermophilus CRL 1190 fermented milk on chronic gastritis in mice. They found that both fermented milk and EPS were able to modulate the gastric inflammatory response and to increase the thickness of the gastric mucus gel layer, which could be used in novel functional foods as an alternative natural therapy for chronic gastritis induced by acetyl-salicylic acid.

Gastritis produced by acetyl-salicylic acid (ASA) consumption is a common disorder worldwide. The use of has been proposed to ameliorate different gastrointestinal tract diseases such as , diarrhea, irritable bowel syndrome, etc. However, little attention has been paid to the use of probiotics in gastric disease. The health-promoting effects ascribed to probiotic strains or fermented foods arise not only from bacteria themselves but also from the metabolites produced during fermentation such as exopolysaccharides (EPS). These polymers have been claimed to modulate the and to display anti-ulcer activities.

A research article to be published on April 7, 2010 in the addresses this question.

The research indicate that the milk fermented with S. thermophilus CRL 1190 and/or its EPS was effective in the therapeutic treatment of chronic gastritis by modulating the immune response of the mice and by increasing the thickness of the gastric mucus gel layer. The fermented milk showed a similar protective effect to omeprazole. The application of this fermented milk and/or its EPS constitutes a potential natural alternative for the prev¬ention and treatment of ASA-associated gastric damage.

Explore further: The war on leukemia: How the battle for cell production could be decisive

More information: Rodríguez C, Medici M, Mozzi F, Font de Valdez G. Therapeutic effect of Streptococcus thermophilus CRL 1190-fermented milk on chronic gastritis. World J Gastroenterol 2010; 16(13): 1622-1630 www.wjgnet.com/1007-9327/full/v16/i13/1622.htm

add to favorites email to friend print save as pdf

Related Stories

A new insight on ethanol-induced gastric mucosa injury

Oct 23, 2008

Many people all over the world indulge themselves in drinking, which is correlated to a wide spectrum of medical, psychological, behavioral, and social problems. It is well known that chronic alcohol abuse may induce gastrointestinal ...

An etiological role for H. pylori in autoimmune gastritis

Jan 14, 2010

Autoimmune type atrophic gastritis is a severe gastric atrophy associated with vitamin B12 deficiency. The reason for the disappearance of acid secreting cells from gastric mucosa is not fully understood, but the role of ...

Can EP4 agonist alleviate gastric lesions?

Nov 18, 2009

Over 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in the world to treat pain, arthritis, fever and other diseases. Nearly 30% of the users suffer from gastric lesions and bleeding. To mitigate NSAIDs' ...

Early treatment of stomach infection may prevent cancer

May 01, 2008

Based on research using a new mouse model of gastritis and stomach cancer, researchers from the Massachusetts Institute of Technology (MIT) say that prompt treatment of Helicobacter pylori (H. pylori) infections reverses ...

Recommended for you

User comments : 0